ReviewFrontiers in physiology2026
Intermittent hypoxic conditioning as a novel strategy for obesity treatment: current evidence and future perspectives.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a metabolic disorder characterized by excessive accumulation of adipose tissue and is a recognized risk factor for numerous chronic diseases. Effective non-pharmacological management of obesity is essential for reducing obesity-related health risks. Hypoxia, defined as insufficient oxygen supply to tissues and cells, is associated with pathological and pathophysiological conditions. In recent years, intermittent hypoxic conditioning (IHC), a potential non-pharmacological intervention under controlled hypoxic conditions, has gained increasing popularity. Recent studies suggest potential benefits of IHC in improving disease-related outcomes. A growing body of research supports its feasibility as an intervention for obesity, highlighting its emerging potential in the treatment of this condition. This review critically discusses the effects of IHC on obesity, with a focus on both animal and human evidence, underlying mechanisms, and safety considerations. By synthesizing current findings, it aims to clarify the state of knowledge and research limitations, and to provide an objective assessment of the applicability of IHC in obesity management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.